federal_register: 2012-29157
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-29157 | Guidance on Food and Drug Administration Oversight of Positron Emission Tomography Drug Products-Questions and Answers; Availability | Notice | The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled "FDA Oversight of PET Drug Products--Questions and Answers." This guidance provides questions and answers that address nearly all aspects of the FDA approval and surveillance processes, including application submission, review, compliance with good manufacturing practices, inspections, registration and listing, and user fees. | 2012-12-04 | 2012 | 12 | https://www.federalregister.gov/documents/2012/12/04/2012-29157/guidance-on-food-and-drug-administration-oversight-of-positron-emission-tomography-drug | https://www.govinfo.gov/content/pkg/FR-2012-12-04/pdf/2012-29157.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled "FDA Oversight of PET Drug Products--Questions and Answers." This guidance provides questions and answers that address nearly all aspects of the FDA approval... |